CAVE CREEK, AZ--(NewMediaWire - Apr 3, 2017) - Endexx
Corporation (OTC
PINK: EDXC), a provider of innovative phytonutrient-based
food and nutritional products, today announced that it has been
granted approval to implement its AutoSpenseTM "alternative
delivery system" for prescription will-call and retail pharmacy
sales support into the first retail pharmacy in Iowa.
Upon integration of Endexx's AutoSpenseTM industrial-grade
automated inventory control and dispensing solutions, customers
will be able to automate the retail process and have access to
inventory and be able to pick up prescriptions after hours. In
addition, the retail pharmacy will have the ability to provide
additional value-added service, increase productivity and sales,
and reduce its operating costs. Endexx has estimated that the
AutoSpenseTM technology reduces transaction time for customers,
allowing for total patient transactions to increase four- to
fivefold daily.
Todd Davis CEO of Endexx said, "Our technology has been
successfully tested in the rigorous dispensary industry and is now
broadening out to the general retail pharmacy chains. We believe
our technology empowers customers and increases efficiency among
the retail markets to improve patient care and give them better
access to their medical care. The major trend that is shifting in
the business of retail pharmacies is on expanding the services
offered, and we believe our technology will serve both customers
and our retail clients to improve front-end sales and overall
revenues and profits."
About Endexx
Endexx provides innovative inventory management and technology
solutions. Endexx, with its collaborative partners and consultants,
develops and distributes two consumable product lines derived from
industrial hemp, which is organic and naturally rich in
phytocannabinoids. Phyto-Bites®, is its CBD-infused soft chews for
dogs. The dog treats are formulated to promote health and support
the reduction of separation anxiety, pain and
inflammation. The company also has two technology products and
services that launched in 2014 -- the M3hub and the Autospense™.
Both products provide essential solutions to promote regulatory
compliance and full accountability through "seed to sale" inventory
management and an "End of Sale" technology integration. Based on
principles developed by the pharmacological industry, the m3hub
platform is the first standardized software solution for tracking
pharmaceutical grade marijuana that maintains compliance with
federal, state and local regulations. It is intended to provide a
smooth transition to eventual federal mandates. The Autospense™ is
a commercial grade inventory control and dispensing device that
provides up-to-the-minute accounting details and ensures both
product and patient security. By automating the dispensing process,
Autospense™ increases productivity and reduces costs for marijuana
retailers, while enhancing their service quality by reducing
transaction time for customers. Websites include: www.cbdunlimited.com, www.endexx.com, www.m3hub.com.
Safe Harbor Notice
This press release may contain "forward-looking statements" within
the meaning of the Private Securities Litigation Reform Act of
1995, such as statements relating to financial results and plans
for future development activities, and are thus prospective.
Forward-looking statements include all statements that are not
statements of historical fact regarding intent, belief or current
expectations of the Company, its directors or its officers.
Investors are cautioned that any such forward-looking statements
are not guarantees of future performance and involve risks and
uncertainties, many of which are beyond the Company's ability to
control. Actual results may differ materially from those projected
in the forward-looking statements. Among the factors that could
cause actual results to differ materially from those indicated in
the forward-looking statements are risks and uncertainties
associated with the Company's business and finances in general,
including the ability to continue and manage its growth,
competition, global economic conditions and other factors discussed
in detail in the Company's periodic filings with the Security and
Exchange Commission. The Company undertakes no obligation to update
any forward-looking statements.